Methylation of the Thyroid-stimulating Hormone Receptor gene in epithelial thyroid tumors: A marker of malignancy and a cause of gene silencing

Cancer Research

Volumn 63, Issue 9, 2003, Pages 2316-2321

  Xing, Mingzhao ^a   Usadel, Henning ^a,c   Cohen, Yoram ^a   Tokumaru, Yutaka ^a   Guo, Zhongmin ^a   Westra, William B ^a   Tong, Betty C ^a   Tallini, Giovanni ^b   Udelsman, Robert ^b   Califano, Joseph A ^a   Ladenson, Paul W ^a   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; THYROTROPIN RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CPG ISLAND; DEMETHYLATION; DNA METHYLATION; DNA SEQUENCE; EPITHELIUM TUMOR; FOLLICULAR CARCINOMA; GENE; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; THYROID ADENOMA; THYROID CANCER; THYROID STIMULATING HORMONE RECEPTOR GENE; THYROID TUMOR;

ADENOMA; DNA METHYLATION; EPITHELIAL CELLS; GENE SILENCING; GENETIC MARKERS; PROMOTER REGIONS (GENETICS); RECEPTORS, THYROTROPIN; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0038561216     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Vassart, G., and Dumont, J. E. Thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr. Rev., 13: 596-611, 1992.
2. Kopp, P. The TSH receptor and its role in thyroid disease. Cell. Mol. Life Sci., 58: 1301-1322, 2001.
3. Tonacchera, M., Agretti, P., Pinchera, A., Rosellini, V., Perri, A., Collecchi, P., Vitti, P., and Chiovato, L. Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: evidence for a new inactivating mutation of the TSH receptor gene. J. Clin. Endocrinol. Metab., 85: 1001-1008, 2000.
4. Ladenson, P. W., Ewertz, M. E., and Dickey, R. A. Practical application of recombinant thyrotropin testing in clinical practice. Endocr. Pract., 7: 195-201, 2001.
5. McDougall, I. R., and Weigel, R. J. Recombinant human thyrotropin in the management of thyroid cancer. Curr. Opin. Oncol., 13: 39-43, 2001.
6. Fatourechi, V., and Hay, I. D. Treating the patient with differentiated thyroid cancer with thyroglobulin-positive iodine-131 diagnostic scan-negative metastases: including comments on the role of serum thyroglobulin monitoring in tumor surveillance. Semin. Nucl. Med., 30: 107-114, 2000.
7. McDougall, I. R. Management of thyroglobulin positive/whole-body scan negative: is Tg positive/131I therapy useful? J. Endocrinol. Investig., 24: 194-198, 2001.
8. Brabant, G., Maenhaut, C., Kohrle, J., Scheumann, G., Dralle, H., Hoang-Vu, C., Hesch, R. D., von zur Muhlen, A., Vassart, G., and Dumont, J. E. Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol. Cell. Endocrinol., 82: R7-R12, 1991.
9. Ohta, K., Endo, T., and Onaya, T. The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues. Biochem. Biophys. Res. Comm., 174: 1148-1153, 1991.
10. Bronnegard, M., Torring, O., Boos, J., Sylven, C., Marcus, C., and Wallin, G. Expression of thyrotropin receptor and thyroid hormone receptor messenger ribonucleic acid in normal, hyperplastic, and neoplastic human thyroid tissues. J. Clin. Endocrinol. Metab., 79: 384-389, 1994.
11. Elisei, R., Pinchera, A., Romei, C., Gryczynska, M., Pohl, V., Maenhaut, C., Fugazzola, L., and Pacini, F. Expression of thyroid stimulating hormone receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype. J. Clin. Endocrinol. Metab., 78: 867-871, 1994.
12. Tanaka, K., Inoue, H., Miki, H., Kansei, K., and Monden, Y. Heterogeneous distribution of thyrotropin receptor messenger ribonucleic acid (TSH-R mRNA) in papillary thyroid carcinoma detected by in situ hybridization. Clin. Endocrinol., 44: 259-267, 1996.
13. Sheils, O. M., and Sweeney, E. C. TSH receptor status of thyroid neoplasms-TaqMan RT-PCR analysis of archival material. J. Pathol., 188: 87-92, 1999.
14. Porcellini, A., Fenzi, G., and Avvedimento, E. V. Mutations of thyrotropin receptor gene. J. Mol. Med., 75: 567-575, 1997.
15. Russo, D., Arturi, F., Chiefari, E., and Filetti, S. Thyrotropin receptor: a role for thyroid tumourigenesis? Forum (Genova), 9: 166-175, 1999.
16. Matsuo, K., Friedman, E., Gejman, P. V., and Fagin, J. A. The thyrotropin receptor (TSH-R) is not an oncogene for thyroid tumors: structural studies of the TSH-R and the α-subunit of Gs in human thyroid neoplasms. J. Clin. Endocrinol. Metab., 76: 1446-1451, 1993.
17. Russo, D., Arturi, F., Schlumberger, M., Caillou, B., Monier, R., Filetti, S., and Suarez, H. G. Activating mutations of the TSH receptor in differentiated thyroid carcinomas. Oncogene, 11: 1907-1911, 1995.
18. Spambalg D., Sharifi N., Elisei R., Gross J. L., Medeiros-Neto G., and Fagin J. A. Structural studies of the thyrotropin receptor and Gs alpha in human thyroid cancers: low prevalence of mutations predicts infrequent involvement in malignant transformation. J. Clin. Endocrinol. Metab., 81: 3898-3901, 1996.
19. Bird, A. P. CpG rich islands and the function of DNA methylation. Nature (Lond.), 321: 209-213, 1986.
20. Bird, A. P. The relationship of DNA methylation to cancer. Cancer Surv., 28: 87-101, 1996.
21. Sidransky, D. Circulating DNA - what we know and what we need to learn. Ann. N. Y. Acad. Sci., 906: 1-4.
22. Baylin, S. B., Esteller, M., Rountree, M. R., Bachman, K. E., Schuebel, K., and Herman, J. G. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet., 10: 687-692, 2001.
23. Califano, J. A., Johns, M. M. III, Westra, W. H., Lango, M. N., Eisele, D., Saji, M., Zeiger, M. A., Udelsman, R., Koch, W. M., and Sidransky, D. An allelotype of papillary thyroid cancer. Int. J. Cancer, 69: 442-444, 1996.
24. Jeronimo, C., Usadel, H., Henrique, R., Oliveira, J., Lopes, C., Nelson, W. G., and Sidransky, D. Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma. J. Natl. Cancer Inst. (Bethesda), 93: 1747-1752, 2001.
25. Nawroz, H., Koch, W., Anker, P., Stroun, M., and Sidransky, D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med., 2: 1035-1037, 1996.
26. Gross, B., Misrahi, M., Sar, S., and Milgrom, E. Composite structure of the human thyrotropin receptor gene. Biochem. Biophys. Res. Commun., 177: 679-687, 1991.
27. Fliss, M. S., Usadel, H., Caballero, O. L., Wu, L., Buta, M. R., Eleff, S. M., Jen, J., and Sidransky, D. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science (Wash. DC), 287: 2017-2019, 2000.
28. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
29. 6methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Cancer Res., 61: 939-942, 2001.
30. Patibandla, S. A., Seetharamaiah, G. S., Dallas, J. S., Thotakura, N. R., Peake, R. L., and Prabhakar, B. S. Differential reactivities of recombinant glycosylated ectodomains of mouse and human thyrotropin receptors with patient autoantibodies. Endocrinology, 138: 1559-1566, 1997.
31. 1 cells. J. Biol. Chem., 274: 10035-10038, 1999.
32. Chen, S. T., Shieh, H. Y., Lin, J. D., Chang, K. S. S., and Lin, K. H. Over-expression of thyroid hormone receptor β1 is associated with thyrotropin receptor gene expression and proliferation in a human thyroid carcinoma cell line. J. Endocrinol., 165: 379-389, 2000.
33. Estour, B., Van Herle, A. J., Juillard, G. J., Totanes, T. L., Sparkes, R. S., Giuliano, A. E., and Klandorf, H. Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). Virchows Arch. B Cell Pathol. Incl. Mol. Pathol., 57: 167-174, 1989.
34. 2 by recognizing specific epitopes on thyrotropin receptor. J. Clin. Endocrinol. Metab., 84: 3283-3292, 1999.
35. Randolph, G. W., and Maniar, D. Medullary carcinoma of the thyroid. Cancer Control, 7: 253-261, 2000.
36. McCaffrey, T. V. Evaluation of the thyroid nodule. Cancer Control, 7:223-228, 2000.
37. Belfiore, A., and La Rosa, G. L. Fine-needle aspiration biopsy of the thyroid. Endocrinol. Metab. Clin. North Am., 30: 361-400, 2001.
38. Ain, K. B. Management of undifferentiated thyroid cancer. Baillieres Best Pract. Res. Clin. Endocrinol. Metab., 14: 615-629, 2000.
39. Ikuyama, S., Niller, H. H., Shimura, H., Akamizu, T., and Kohn, L. D. Characterization of the 5′-flanking region of the rat thyrotropin receptor gene. Mol. Endocrinol., 6: 793-804, 1992.
40. Yokomori, N., Tawata, M., Saito, T., Shimura, H., and Onaya, T. Regulation of the rat thyroid receptor gene by the methylation-sensitive transcription factor GA-binding protein. Mol. Endocrinol., 12: 1241-1249, 1998.
41. Berlingieri, M. T., Akamizu, T., Fusco, A., Grieco, M., Colletta, G., Cirafici, A. M., Ikuyama, S., Kohn, L. D., and Vecchio, G. Thyrotropin receptor gene expression in oncogene-transfected rat thyroid cells: correlation between transformation, loss of thyrotropin receptor gene expression. Biochem. Biophys. Res. Commun., 173: 172-178, 1990.
42. Venkataraman, G. M., Yatin, M., Marcinek, R., and Ain, K. B. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: relationship to human Na+/I-symporter gene methylation status. J. Clin. Endocrinol. Metab., 84: 2449-2457, 1999.
43. Park, H. J., Kim, J. Y., Park, K. Y., Gong, G., Hong, S. J., and Ahn, I. M. Expressions of human sodium iodide symporter mRNA in primary and metastatic papillary thyroid carcinomas. Thyroid, 10: 211-217, 2000.
44. Ringel, M. D., Anderson,. J, Souza, S. L., Burch, H. B., Tambascia, M., Shriver, C. D., and Tuttle, R. M. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer. Mod. Pathol., 14: 289-296, 2001.
45. Russo, D., Manole, D., Arturi, F., Suarez, H. G., Schlumberger, M., Filetti, S., and Derwahl, M. Absence of sodium/iodide symporter gene mutations in differentiated human thyroid carcinomas. Thyroid, 11: 37-39, 2001.
46. Scheinbart, L. S., Johnson, M. A., Gross, L. A., Edelstein, S. R., and Richardson, B. C. Procainamide inhibits DNA methyltransferase in a human T cell line. J. Rheumatol., 18: 530-534, 1991.
47. Lin, X., Asgari, K., Putzi, M. J., Gage, W. R., Yu, X., Cornblatt, B. S., Kumar, A., Piantadosi, S., DeWeese, T. L., De Marzo, A. M., and Nelson, W. G. Reversal of GSTP1 CpG island hypermethylation and reactivation of π-class glutathione Stransferase (GSTP1) expression in human prostate cancer cells by treatment with procainamide. Cancer Res., 61: 8611-8616, 2001.